Traditional weight-based vancomycin dosing is inadequate in critically ill trauma patients

Area of Science:

• Pharmacology
• Critical Care Medicine
• Infectious Diseases

Background:

• Vancomycin is crucial for treating pneumonia in critically ill patients.
• Weight-based dosing is recommended to optimize vancomycin serum levels.
• Adherence to dosing guidelines is essential for effective treatment and minimizing toxicity.

Purpose of the Study:

• Evaluate compliance with weight-based vancomycin dosing for pneumonia in critically ill injured patients.
• Assess the achievement of therapeutic vancomycin serum trough levels.
• Determine the incidence of vancomycin-induced nephrotoxicity.

Main Methods:

• Retrospective review of critically ill injured patients receiving vancomycin.
• Comparison of initial weight-based vancomycin doses with actual prescribed doses.
• Analysis of vancomycin trough levels and nephrotoxicity incidence.

Main Results:

• Only 40% of patients received the recommended weight-based vancomycin dose (30 mg/kg/day).
• Patients receiving weight-based dosing were more likely to achieve therapeutic trough levels (58% vs. 33%).
• Weight-based dosing led to achieving therapeutic levels faster, with 33% achieving it on the first trough compared to 5.6%.

Conclusions:

• Appropriate weight-based vancomycin dosing is underutilized in critically ill injured patients.
• Weight-based vancomycin dosing significantly improves the likelihood of achieving therapeutic serum levels.
• Optimizing vancomycin dosing is critical for effective pneumonia treatment in this population.